Yatharth Hospital Approves ₹3,150 Crore 24.87% Preferential Issue To Rasmalai

Board approved preferential issue to Rasmalai Ltd, Cyprus for up to Rs 3150 Cr via 1.30 Cr shares and 1.89 Cr warrants at Rs 985.17, 24.87% fully diluted stake. First large external equity since IPO/QIP phase after debt-funded buys; funds long bed build-out. Needs EGM 15 Oct and CCI plus other approvals; investor stays public, no change of control. Adds 2 investor nominee directors with veto and pre-emptive rights, 3-year promoter lock-in and profit-share above hurdle; use of proceeds and warrant exercise timing undisclosed.